Product Code: GVR-1-68038-084-2
Durable Medical Equipment Market Growth & Trends
The global durable medical equipment market size is expected to reach USD 331.1 billion and register a CAGR of 5.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by a rise in chronic diseases, such as kidney failure and cancer. Moreover, technological advancements along with a strong reimbursement scenario are likely to boost the durable medical equipment (DME) market over the forecast period.
The growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and a lack of skilled professionals may limit the market growth.
The COVID-19 pandemic has initially affected the market due to the shortage of supply of the product. The market players have resulted in a decline in operations, sales, and revenue during the pandemic. The outbreak has temporarily changed the customer's spending habits due to the restrictions imposed by the government. The pandemic has resulted in rising costs of the product and post-sale services for the recovery of financial loss incurred by the market players.
The availability of technologically advanced products has also played an important role in positively impacting the growth of the market. Countries such as U.S., UK, and Germany are innovators and early adopters of advanced technologies, thus these are the most important customers for medical device markets with rapid technological innovations. Technological breakthroughs concentrating on increasing efficiency are expected to occur during the forecast period, thereby driving market growth.
Durable Medical Equipment Market Report Highlights
- Monitoring and therapeutic devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability.
- Home healthcare is anticipated to be the fastest-growing segment in the forecast period as it is less expensive and preferred by aged people.
- North America led the market with the largest share in 2022 and will witness steady growth in the future on account of the presence of major companies in the region.
- Asia Pacific is expected to register the highest CAGR in the forecast period owing to the presence of a large target population base and improving healthcare facilities.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Implant Shape
- 1.1.3. Application
- 1.1.4. End-use
- 1.1.5. Country scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Snapshot
Chapter 3. DME Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. DME Market Analysis Tools
- 3.4.1. Industry analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.3. Major deals & strategic alliances analysis
Chapter 4. DME Market by Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2022 & 2030
- 4.2. Segment Dashboard
- 4.3. Global DME Market by Product Outlook
- 4.3.1. Personal Mobility Devices
- 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.2. Wheelchairs
- 4.3.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.3. Scooters
- 4.3.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.4. Walkers & Rollators
- 4.3.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.5. Cranes & Crutches
- 4.3.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.6. Door Openers
- 4.3.1.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.7. Other Devices
- 4.3.1.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.2. Bathroom Safety Devices & Medical Furniture
- 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.2.2. Commodes & Toilets
- 4.3.2.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.2.3. Mattress & Bedding Devices
- 4.3.2.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3. Monitoring & Therapeutic Devices
- 4.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.2. Blood Glucose Monitors
- 4.3.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.3. Continuous Passive Motion Therapy
- 4.3.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.4. Infusion Pumps
- 4.3.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.5. Nebulizers
- 4.3.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.6. Oxygen Equipment
- 4.3.3.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.7. CPAP
- 4.3.3.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.8. Suction Pump
- 4.3.3.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.9. Traction Equipment
- 4.3.3.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3.10. Other Equipment
- 4.3.3.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. DME Market: By End-use Estimates & Trend Analysis
- 5.1. End-use Market Share, 2022 & 2030
- 5.2. Segment Dashboard
- 5.3. Global DME Market by End-use Outlook
- 5.3.1. Hospitals
- 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2. Nursing Homes
- 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.3. Home Healthcare
- 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.4. Others
- 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. DME Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2022 & 2030
- 6.2. County Market Dashboard
- 6.3. Regional Market Snapshot
- 6.4. Regional Market Share and Leading Players, 2022
- 6.4.1. North America
- 6.4.2. Europe
- 6.4.3. Asia Pacific
- 6.4.4. Latin America
- 6.4.5. Middle East and Africa
- 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 6.5.1. North America
- 6.5.2. Europe
- 6.5.3. Asia Pacific
- 6.5.4. Latin America
- 6.5.5. Middle East and Africa
- 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
- 6.7. North America
- 6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.2. U.S.
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Regulatory Structure/Reimbursement Scenario
- 6.7.2.3. Competitive Scenario
- 6.7.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.3. Canada
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Regulatory Structure/Reimbursement Scenario
- 6.7.3.3. Competitive Scenario
- 6.7.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8. Europe
- 6.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.2. U.K.
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Regulatory Structure/Reimbursement Scenario
- 6.8.2.3. Competitive Scenario
- 6.8.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.3. Germany
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Regulatory Structure/Reimbursement Scenario
- 6.8.3.3. Competitive Scenario
- 6.8.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.4. France
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Regulatory Structure/Reimbursement Scenario
- 6.8.4.3. Competitive Scenario
- 6.8.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.5. Italy
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Regulatory Structure/Reimbursement Scenario
- 6.8.5.3. Competitive Scenario
- 6.8.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.6. Spain
- 6.8.6.1. Key Country Dynamics
- 6.8.6.2. Regulatory Structure/Reimbursement Scenario
- 6.8.6.3. Competitive Scenario
- 6.8.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.7. Denmark
- 6.8.7.1. Key Country Dynamics
- 6.8.7.2. Regulatory Structure/Reimbursement Scenario
- 6.8.7.3. Competitive Scenario
- 6.8.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.8. Sweden
- 6.8.8.1. Key Country Dynamics
- 6.8.8.2. Regulatory Structure/Reimbursement Scenario
- 6.8.8.3. Competitive Scenario
- 6.8.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.9. Norway
- 6.8.9.1. Key Country Dynamics
- 6.8.9.2. Regulatory Structure/Reimbursement Scenario
- 6.8.9.3. Competitive Scenario
- 6.8.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9. Asia Pacific
- 6.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.2. Japan
- 6.9.2.1. Key Country Dynamics
- 6.9.2.2. Regulatory Structure/Reimbursement Scenario
- 6.9.2.3. Competitive Scenario
- 6.9.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.3. China
- 6.9.3.1. Key Country Dynamics
- 6.9.3.2. Regulatory Structure/Reimbursement Scenario
- 6.9.3.3. Competitive Scenario
- 6.9.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.4. India
- 6.9.4.1. Key Country Dynamics
- 6.9.4.2. Regulatory Structure/Reimbursement Scenario
- 6.9.4.3. Competitive Scenario
- 6.9.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.5. Australia
- 6.9.5.1. Key Country Dynamics
- 6.9.5.2. Regulatory Structure/Reimbursement Scenario
- 6.9.5.3. Competitive Scenario
- 6.9.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.6. South Korea
- 6.9.6.1. Key Country Dynamics
- 6.9.6.2. Regulatory Structure/Reimbursement Scenario
- 6.9.6.3. Competitive Scenario
- 6.9.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.7. Thailand
- 6.9.7.1. Key Country Dynamics
- 6.9.7.2. Regulatory Structure/Reimbursement Scenario
- 6.9.7.3. Competitive Scenario
- 6.9.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.10. Latin America
- 6.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.10.2. Brazil
- 6.10.2.1. Key Country Dynamics
- 6.10.2.2. Regulatory Structure/Reimbursement Scenario
- 6.10.2.3. Competitive Scenario
- 6.10.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.10.3. Mexico
- 6.10.3.1. Key Country Dynamics
- 6.10.3.2. Regulatory Structure/Reimbursement Scenario
- 6.10.3.3. Competitive Scenario
- 6.10.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.10.4. Argentina
- 6.10.4.1. Key Country Dynamics
- 6.10.4.2. Regulatory Structure/Reimbursement Scenario
- 6.10.4.3. Competitive Scenario
- 6.10.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.11. Middle East & Africa
- 6.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.11.2. South Africa
- 6.11.2.1. Key Country Dynamics
- 6.11.2.2. Regulatory Structure/Reimbursement Scenario
- 6.11.2.3. Competitive Scenario
- 6.11.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.11.3. Saudi Arabia
- 6.11.3.1. Key Country Dynamics
- 6.11.3.2. Regulatory Structure/Reimbursement Scenario
- 6.11.3.3. Competitive Scenario
- 6.11.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.11.4. UAE
- 6.11.4.1. Key Country Dynamics
- 6.11.4.2. Regulatory Structure/Reimbursement Scenario
- 6.11.4.3. Competitive Scenario
- 6.11.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.11.5. Kuwait
- 6.11.5.1. Key Country Dynamics
- 6.11.5.2. Regulatory Structure/Reimbursement Scenario
- 6.11.5.3. Competitive Scenario
- 6.11.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2022
- 7.3.4. Invacare Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Procedure benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Arjohuntleigh
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Procedure benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Stryker Corporation
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Procedure benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Hill Rom, Inc.
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Procedure benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Drive Medical
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Procedure benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. GF Health Products, Inc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Procedure benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Sunrise Medical
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Procedure benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Medline Industries, Inc.
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Procedure benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Carex Health Brands, Inc.
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Procedure benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Becton, Dickinson & Company
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Procedure benchmarking
- 7.3.13.4. Strategic initiatives
- 7.3.14. General Electric Company
- 7.3.14.1. Company overview
- 7.3.14.2. Financial performance
- 7.3.14.3. Procedure benchmarking
- 7.3.14.4. Strategic initiatives
- 7.3.15. Medtronic PLC
- 7.3.15.1. Company overview
- 7.3.15.2. Financial performance
- 7.3.15.3. Procedure benchmarking
- 7.3.15.4. Strategic initiatives
- 7.3.16. Compass Health Brands
- 7.3.16.1. Company overview
- 7.3.16.2. Financial performance
- 7.3.16.3. Procedure benchmarking
- 7.3.16.4. Strategic initiatives
- 7.3.17. Getinge AB
- 7.3.17.1. Company overview
- 7.3.17.2. Financial performance
- 7.3.17.3. Procedure benchmarking
- 7.3.17.4. Strategic initiatives
- 7.3.18. Resmed, Inc.
- 7.3.18.1. Company overview
- 7.3.18.2. Financial performance
- 7.3.18.3. Procedure benchmarking
- 7.3.18.4. Strategic initiatives